Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nice
Clinical trial register · France

Clinical Trials in Nice, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 35 Nice 32 Marseille 28 Toulouse 26 Montpellier 23
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Centre Hospitalier Universitaire de Nice194 AbbVie32 Merck Sharp & Dohme LLC21 Novartis Pharmaceuticals20 Centre Antoine Lacassagne19 Clear sponsor filter
Site location
Paris35 Nice32 Marseille28 Toulouse26 Montpellier23
All 72 locations
Target enrolment
to

Trials with a site in Nice

32 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
AbbVie
Phase 3
520
Nice, Tours, Vandœuvre-lès-Nancy, Nantes, Avignon
2026-11-30
Recruiting
AbbVie
Phase 2/3
660
Nice, Marseille, Pessac, Angers, Amiens, Paris
2026-06-30
Recruiting
AbbVie
Phase 3
561
Nice, Lyon, Bordeaux, Nantes, Écully, Créteil, Marseille, Paris
2025-11-05
Recruiting
AbbVie
Phase 1
135
Nice, Marseille, Lille, Tours, Toulouse
2025-08-07
Active, closed
AbbVie
Phase 3
573
Nice, Montpellier, Créteil, St-Priest-en-Jarez, Paris
2025-06-17
Recruiting
AbbVie
Phase 2
110
Caen, Plérin, Vandœuvre-lès-Nancy, Lille, Nice, Pierre-Bénite, La Roche-sur-Yon, Paris
2025-05-28
Recruiting
AbbVie
Phase 2
120
Nice, Caluire-et-Cuire, Chambray-lès-Tours, Bordeaux, Orléans
2025-04-11
Recruiting
AbbVie
Phase 1/2
252
Bordeaux, Saint-Herblain, Montpellier, Nice, Villejuif, Paris
2025-03-06
Recruiting
AbbVie
Observational
1,200
Nice, Caluire-et-Cuire, Clermont-Ferrand, Échirolles, Besançon, Arras, Lille, Montpellier
2025-01-31
Recruiting
AbbVie
Phase 2
590
Nice, Montpellier, Rennes, Vandœuvre-lès-Nancy, Pessac, Toulouse, St-Priest-en-Jarez, Pierre-Bénite
2024-09-04
Recruiting
AbbVie
Phase 3
170
Metz, Créteil, Paris, St-Priest-en-Jarez, Nice, Bayonne, Chambéry, Amiens
2024-08-05
Active, closed
AbbVie
Phase 2
156
Nice, Toulouse, Créteil, Nantes, St-Priest-en-Jarez
2024-03-23
Active, closed
AbbVie
Observational
1,200
Nice, Clermont, Lyon, Marseille, Dijon, Pessac, Toulouse, Montpellier
2024-02-19
Active, closed
AbbVie
Phase 3
614
Nice, Bordeaux, Toulouse, Créteil, Lyon
2023-12-19
Recruiting
AbbVie
Phase 3
1,500
Nice, Rennes, Bordeaux, Toulouse, Reims, Nantes, Lyon, Brest
2023-10-11
Active, closed
AbbVie
Phase 3
1,328
Nice, Bordeaux, Reims, Nantes, Lyon, Antony
2023-06-21
Active, closed
AbbVie
Observational
1,019
Nice, Marseille, Besançon, Brest, Quimper, Nîmes, Pessac, Colmar
2023-06-09
Active, closed
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
NCT05527184Endometrial Cancer, High Grade Serous Adenocarcinoma of Ovary, Primary Peritoneal Carcinoma, Fallopian Tube Cancer
DrugIMGN151
AbbVie
Phase 1
256
Saint-Herblain, Nice, Lyon, Pierre-Bénite, Villejuif
2023-01-11
Active, closed
AbbVie
Observational
785
Nice, Marseille, Besançon, Nîmes, Colmar, Toulouse, Montpellier, La Tronche
2022-08-15
Active, closed
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
NCT05407636AMD, nAMD, Wet Age-related Macular Degeneration, wAMD
DrugsEylea·Aflibercept
AbbVie
Phase 3
735
Nice, Lyon, Dijon, Toulouse, Paris, Nantes, Marseille, Créteil
2022-01-13
Active, closed
AbbVie
Phase 1
520
Bordeaux, Saint-Herblain, Nice, Lyon, Villejuif, Dijon, Paris
2021-10-13
Active, closed
AbbVie
Phase 3
527
Nice, Clermont, Marseille, Pessac, Montpellier, La Tronche, Reims, Vandœuvre-lès-Nancy
2020-09-30
Active, closed
AbbVie
Phase 3
531
Nice, Pessac, La Tronche, Lille, Nantes, Marseille, Rouen, Avignon
2020-09-10
Active, closed
AbbVie
Phase 3
330
Nice, Nîmes, Pessac, Nantes, Pierre-Bénite, Chambéry, Angers, Paris
2020-08-31
Active, closed
AbbVie
Phase 1
85
Nice, Amiens, Paris, Toulouse
2019-11-08
Active, closed
AbbVie
Phase 1/2
218
Marseille, Toulouse, Paris, Nice, Pierre-Bénite, Le Chesnay
2019-11-06
Active, closed
AbbVie
Phase 3
1,242
Nice, Marseille, Montpellier, Vandœuvre-lès-Nancy, Pessac, Saint Priest EN Jarez, Amiens, Nantes
2018-08-28
Active, closed
AbbVie
Phase 3
1,533
Nice, Marseille, Tours, Bordeaux, Reims
2018-08-09
Active, closed
AbbVie
Phase 3
1,336
Nice, Montpellier, La Tronche, Vandœuvre-lès-Nancy, Pessac, Lille, St-Priest-en-Jarez, Pierre-Bénite
2018-04-09
Active, closed
AbbVie
Phase 3
747
Nice, Pessac, Toulouse, Montpellier, La Tronche, Vandœuvre-lès-Nancy, Lille, Valenciennes
2018-03-21
Active, closed
AbbVie
Phase 3
950
Nice, Montpellier, Lille, Pierre-Bénite, La Roche-sur-Yon, Saint-Etienne
2017-01-31
Active, closed
AbbVie
Observational
8,250
Nice, Clermont, Marseille, Toulouse, Montpellier, La Tronche, Reims, Vandœuvre-lès-Nancy
2013-04-29
Rows per page Showing 1–32 of 32
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 October 2026. https://priyalifescience.com/clinical-trials-france/city/nice

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 32 of those studies with a site in Nice that also match the filters currently applied.

How many clinical trials are recruiting in Nice?

10 of the 32 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 1 have not yet opened recruitment, 21 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nice), 32 studies
PhaseStudiesRecruitingShare
Phase 316350%
Observational5115.6%
Phase 14112.5%
Phase 24312.5%
Phase 1/2216.3%
Phase 2/3113.1%

Most active sponsors

Lead sponsors with the most studies (Nice)
Lead sponsorStudiesRecruiting
AbbVie3210
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.